| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
| 03/24/1993 | EP0346413B1 Potentiation of erythropoiesis |
| 03/24/1993 | EP0345315B1 Ps2 protein derivative |
| 03/24/1993 | EP0211894B1 Fsh |
| 03/24/1993 | CN1070227A DNA sequences encoding gelonin polypeptide |
| 03/23/1993 | US5196516 Pseudorabies virus vaccine |
| 03/23/1993 | US5196513 Immunodiagnosis |
| 03/23/1993 | US5196511 Peptides and antibodies that inhibit integrin-ligand binding |
| 03/23/1993 | US5196438 Amino acid derivatives |
| 03/23/1993 | US5196404 Inhibitors of thrombin |
| 03/23/1993 | US5196403 Method of inhibiting platelet activation |
| 03/23/1993 | US5196402 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
| 03/23/1993 | US5196338 Recombinant vectors for Haemophilus influenzae peptides and proteins |
| 03/23/1993 | US5196337 Human monoclonal antibody, and its production and use |
| 03/23/1993 | US5196334 Urogenital sinus derived growth inhibitory factor |
| 03/23/1993 | US5196323 Antiviral and immunoregulatory activities |
| 03/23/1993 | US5196319 Primary biliary cirrhosis autoantigen |
| 03/23/1993 | US5196310 Hybrid cell line for producing monoclonal antibody to a human monocyte antigen, antibody, and methods |
| 03/23/1993 | US5196196 Use of protease nexin-I in wound dressings |
| 03/23/1993 | US5196195 Use of arginase to control nitric oxide formation |
| 03/23/1993 | US5196193 Antivenoms and methods for making antivenoms |
| 03/23/1993 | US5196192 Administering inhibin and activin to suppress transplant rejection or to treat autoimmune disease |
| 03/23/1993 | US5196191 Temporal gamma-interferon administration for allergies |
| 03/23/1993 | US5196185 Collagen-based wound dressing and method for applying same |
| 03/23/1993 | CA1315042C2 Methods and compositions for preparation of the tetrapeptide, h-x-omega-u-z-y-tyr-r' |
| 03/23/1993 | CA1315041C2 Methods and compositions for preparation of the tetrapeptide, alpha-t-x-omega-u-z-y-tyr-r' |
| 03/23/1993 | CA1315040C2 Methods and compositions for preparation of the pentapeptide, alpha-t-omega-t' -arg-x-omega-u-z-y-tyr-r' |
| 03/19/1993 | CA2078384A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
| 03/18/1993 | WO1993005394A1 Identifying membranolytic compounds and precursors thereof |
| 03/18/1993 | WO1993005172A1 Morphogenic protein screening method |
| 03/18/1993 | WO1993005169A1 Hybrid cytokines |
| 03/18/1993 | WO1993005168A1 Dna sequences encoding gelonin polypeptide |
| 03/18/1993 | WO1993005161A1 Lactobacilli having genetically modified bile salt hydrolytic activity, production and use thereof |
| 03/18/1993 | WO1993005157A1 Ribosomal structure derived from the genomic rna structure of the delta hepatitus virus |
| 03/18/1993 | WO1993005150A1 Collagen-induced platelet aggregation inhibitor |
| 03/18/1993 | WO1993005148A1 Mutated growth factor receptor as medicament and its use for treating cancer |
| 03/18/1993 | WO1993005147A1 Defective interfering hiv particles with chimeric cd4-env |
| 03/18/1993 | WO1993005073A1 ANGIOTENSIN IIcAMP/VASOPRESSINV2 RECEPTORS AND RELATED MOLECULES AND METHODS |
| 03/18/1993 | WO1993005072A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
| 03/18/1993 | WO1993005070A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | WO1993005069A1 New isosteric peptides |
| 03/18/1993 | WO1993005067A1 Topical fibrinogen complex |
| 03/18/1993 | WO1993005066A1 Heat labile toxin of bordetella |
| 03/18/1993 | WO1993005061A1 Cloning and characterization of a cardiac adenylyl cyclase |
| 03/18/1993 | WO1993004710A2 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
| 03/18/1993 | WO1993004700A1 Vα12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
| 03/18/1993 | WO1993004699A1 Therapeutic method for iddm |
| 03/18/1993 | WO1993004696A1 Method and composition for killing malaria parasites |
| 03/18/1993 | WO1993004695A1 T cell receptor-based therapy for rheumatoid arthritis |
| 03/18/1993 | WO1993004694A1 A method for treatment of patients with chronic liver disease |
| 03/18/1993 | WO1993004693A1 Synergistic inhibition of hiv-1 |
| 03/18/1993 | WO1993004692A1 Morphogen-induced modulation of inflammatory response |
| 03/18/1993 | WO1993004691A1 Compositions and methods for treating wounds |
| 03/18/1993 | WO1993004690A1 Method for the treatment of the complications and pathology of diabetes |
| 03/18/1993 | WO1993004678A1 Antimicrobial preservation of platelets and blood factors |
| 03/18/1993 | WO1993004672A1 Method for enhancing the immune system in a host employing liposome-encapsulated polypeptides |
| 03/18/1993 | WO1992020711A3 Lhrh antagonists and intermediate products |
| 03/18/1993 | DE4130774A1 Agent for treatment of selectively determinable esp. metastatic cancer cells - comprises mainly dextrose and insulin to aid insulin uptake with iodine@ to kill the cell |
| 03/18/1993 | DE4130546A1 Knochenwachstumsfoerdernde zusammensetzung Knochenwachstumsfoerdernde composition |
| 03/18/1993 | DE4130545A1 Knochenwachstumsfoerdernde zusammensetzung Knochenwachstumsfoerdernde composition |
| 03/18/1993 | DE4130221A1 Use of proteolytic enzymes e.g. papain or trypsin |
| 03/18/1993 | CA2118695A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | CA2117174A1 Collagen-induced platelet aggregation inhibitor |
| 03/18/1993 | CA2117073A1 Mutated growth factor receptor as a drug and its use for the treatment of cancer |
| 03/18/1993 | CA2117058A1 Topical fibrinogen complex |
| 03/18/1993 | CA2116549A1 Compositions and methods for treating wounds |
| 03/18/1993 | CA2116533A1 Hybrid cytokines |
| 03/18/1993 | CA2116527A1 New isosteric peptides |
| 03/18/1993 | CA2116526A1 T cell receptor-based therapy for rheumatoid arthritis |
| 03/18/1993 | CA2116453A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 03/18/1993 | CA2116339A1 V.alpha.12.1 t-cell receptor-specific reagents for diagnosing and treating rheumatoid arthritis |
| 03/17/1993 | EP0532466A2 Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use |
| 03/17/1993 | EP0532465A1 Protein fraction for cosmetic and dermatological care of the skin |
| 03/17/1993 | EP0531798A2 Method for detecting, identifying, and quantitating organisms and viruses |
| 03/17/1993 | EP0531539A1 Lyophilized monoclonal antibody preparation |
| 03/17/1993 | EP0531537A1 Hirudin analogue or salt thereof, production thereof, and anticoagulant containing the same as active ingredient |
| 03/17/1993 | EP0531530A1 Process for producing protein |
| 03/17/1993 | EP0531472A1 Humanized and chimeric monoclonal antibodies |
| 03/17/1993 | EP0531467A1 Polypeptide fraction affording protection to cells against mechanical damage and assay |
| 03/17/1993 | EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan. |
| 03/17/1993 | EP0531442A1 Method for using fibronectin in conjunction with percutaneous transluminal coronary angioplasty |
| 03/17/1993 | EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 03/17/1993 | EP0531425A1 Wound healing |
| 03/17/1993 | EP0531407A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 03/17/1993 | EP0531365A1 Diagnosis and treatment of viral hepatitis |
| 03/17/1993 | EP0531342A1 Cyclized and linear therapeutic peptides |
| 03/17/1993 | EP0516685A4 Artificial tears |
| 03/17/1993 | EP0390829B1 Process for producing syngeneic cells, and their use |
| 03/17/1993 | EP0317641B1 Fused protein containing lymphotoxin |
| 03/16/1993 | US5194654 Viricides for retroviral infections such as aids |
| 03/16/1993 | US5194608 Hypotensive agents; inhibits renin-angiotensin system |
| 03/16/1993 | US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
| 03/16/1993 | US5194600 Genes which participate in β-glucan assembly and use thereof |
| 03/16/1993 | US5194596 Production of vascular endothelial cell growth factor |
| 03/16/1993 | US5194593 Monoclonal antibodies |
| 03/16/1993 | US5194592 Monoclonal antibodies to novel polypeptide derivatives of human granulocyte colony stimulating factor |
| 03/16/1993 | US5194590 Acellular red blood cell substitute |
| 03/16/1993 | US5194589 Leech protein having anticoagulant and antimetastatic properties |
| 03/16/1993 | US5194588 Aminoalcohol intermediates for peptide derivatives |